These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37280108)

  • 1. Glioblastoma Stem Cell Targeting Peptide Isolated Through Phage Display Binds Cadherin 2.
    Kim J; Potez M; She C; Huang P; Wu Q; Bao S; Rich JN; Liu JKC
    Stem Cells; 2023 Aug; 41(8):762-774. PubMed ID: 37280108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of phage display biopanning as a tool to design CAR-T cells against glioma stem cells.
    Potez M; Snedal S; She C; Kim J; Thorner K; Tran TH; Ramello MC; Abate-Daga D; Liu JKC
    Front Oncol; 2023; 13():1124272. PubMed ID: 37035164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phage display targeting identifies EYA1 as a regulator of glioblastoma stem cell maintenance and proliferation.
    Kim J; She C; Potez M; Huang P; Wu Q; Prager BC; Qiu Z; Bao S; Rich JN; Liu JKC
    Stem Cells; 2021 Jul; 39(7):853-865. PubMed ID: 33594762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phage display discovery of novel molecular targets in glioblastoma-initiating cells.
    Liu JK; Lubelski D; Schonberg DL; Wu Q; Hale JS; Flavahan WA; Mulkearns-Hubert EE; Man J; Hjelmeland AB; Yu J; Lathia JD; Rich JN
    Cell Death Differ; 2014 Aug; 21(8):1325-39. PubMed ID: 24832468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a peptide that interacts with Nestin protein expressed in brain cancer stem cells.
    Beck S; Jin X; Yin J; Kim SH; Lee NK; Oh SY; Jin X; Kim MK; Kim EB; Son JS; Kim SC; Nam DH; Kim SH; Kang SK; Kim H; Choi YJ
    Biomaterials; 2011 Nov; 32(33):8518-28. PubMed ID: 21880363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting A20 decreases glioma stem cell survival and tumor growth.
    Hjelmeland AB; Wu Q; Wickman S; Eyler C; Heddleston J; Shi Q; Lathia JD; Macswords J; Lee J; McLendon RE; Rich JN
    PLoS Biol; 2010 Feb; 8(2):e1000319. PubMed ID: 20186265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelin-forming cell-specific cadherin-19 is a marker for minimally infiltrative glioblastoma stem-like cells.
    Zorniak M; Clark PA; Kuo JS
    J Neurosurg; 2015 Jan; 122(1):69-77. PubMed ID: 25361488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia.
    Mao XG; Xue XY; Wang L; Zhang X; Yan M; Tu YY; Lin W; Jiang XF; Ren HG; Zhang W; Song SJ
    Neuro Oncol; 2013 Jul; 15(7):865-79. PubMed ID: 23645533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
    Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
    Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Targeting Peptides Search Strategy for the Delivery of Therapeutic and Diagnostic Molecules to Tumor Cells.
    Dmitrieva MD; Voitova AA; Dymova MA; Richter VA; Kuligina EV
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma.
    Jiang W; Finniss S; Cazacu S; Xiang C; Brodie Z; Mikkelsen T; Poisson L; Shackelford DB; Brodie C
    Oncotarget; 2016 Aug; 7(35):56456-56470. PubMed ID: 27486821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
    Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
    Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-quadruplex ligand RHPS4 radiosensitizes glioblastoma xenograft in vivo through a differential targeting of bulky differentiated- and stem-cancer cells.
    Berardinelli F; Tanori M; Muoio D; Buccarelli M; di Masi A; Leone S; Ricci-Vitiani L; Pallini R; Mancuso M; Antoccia A
    J Exp Clin Cancer Res; 2019 Jul; 38(1):311. PubMed ID: 31311580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular targeting of TRF2 suppresses the growth and tumorigenesis of glioblastoma stem cells.
    Bai Y; Lathia JD; Zhang P; Flavahan W; Rich JN; Mattson MP
    Glia; 2014 Oct; 62(10):1687-98. PubMed ID: 24909307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-cadherin upregulation mediates adaptive radioresistance in glioblastoma.
    Osuka S; Zhu D; Zhang Z; Li C; Stackhouse CT; Sampetrean O; Olson JJ; Gillespie GY; Saya H; Willey CD; Van Meir EG
    J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33720050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-derived glioblastoma stem cells respond differentially to targeted therapies.
    Kanabur P; Guo S; Simonds GR; Kelly DF; Gourdie RG; Verbridge SS; Sheng Z
    Oncotarget; 2016 Dec; 7(52):86406-86419. PubMed ID: 27863440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verteporfin inhibits oxidative phosphorylation and induces cell death specifically in glioma stem cells.
    Kuramoto K; Yamamoto M; Suzuki S; Sanomachi T; Togashi K; Seino S; Kitanaka C; Okada M
    FEBS J; 2020 May; 287(10):2023-2036. PubMed ID: 31868973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factor independence underpins a paroxysmal, aggressive Wnt5a
    Trivieri N; Visioli A; Mencarelli G; Cariglia MG; Marongiu L; Pracella R; Giani F; Soriano AA; Barile C; Cajola L; Copetti M; Palumbo O; Legnani F; DiMeco F; Gorgoglione L; Vescovi AL; Binda E
    J Exp Clin Cancer Res; 2022 Apr; 41(1):139. PubMed ID: 35414102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43
    Pelaz SG; Jaraíz-Rodríguez M; Álvarez-Vázquez A; Talaverón R; García-Vicente L; Flores-Hernández R; Gómez de Cedrón M; Tabernero M; Ramírez de Molina A; Lillo C; Medina JM; Tabernero A
    EBioMedicine; 2020 Dec; 62():103134. PubMed ID: 33254027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.